Ophthalmology
A clear line of sight to commercial success
Aging global populations, rising rates of diabetes and hypertension, and increasing incidence of autoimmune diseases that affect eye health are all contributing to the growing need for novel therapies that more effectively treat ocular diseases. Your compound is racing to be among them.
PPD’s team of dedicated ophthalmological professionals can quickly determine the market potential for your ophthalmic drug or device using our full suite of innovative end-to-end drug development and study design capabilities. Our experts navigate complex worldwide trials with an expansive network of experienced ophthalmic research sites and professionals, while offering patient services that improve patient recruitment and increase retention.
Ophthalmic product experts can drive your ocular disease therapy’s development
On your way to commercialization, we enable you find the clearest path for your eye disease therapy that avoids unnecessary delays in the drug development process with proactive expertise optimizing your study’s design from the very start.
Whether you are researching neurological disorders that affect the eye or systemic neurological diseases with ocular manifestations as the result of the deterioration of the brain, such as Parkinson’s and Alzheimer’s diseases, PPD has a dedicated global team with extensive experience in conducting ocular clinical trials.
